XASXANN
Market cap2.99bUSD
Dec 20, Last price
32.97AUD
1D
-0.06%
1Q
3.22%
Jan 2017
33.43%
Name
Ansell Ltd
Chart & Performance
Profile
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia. P. D. Holdings Pty. Ltd. operates as a current subsidiary of Ansell Limited.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 1,619,300 -0.90% | 1,634,067 -11.71% | 1,850,821 -9.28% | |||||||
Cost of revenue | 1,440,400 | 1,437,201 | 1,617,205 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 178,900 | 196,866 | 233,616 | |||||||
NOPBT Margin | 11.05% | 12.05% | 12.62% | |||||||
Operating Taxes | 31,200 | 39,196 | 46,079 | |||||||
Tax Rate | 17.44% | 19.91% | 19.72% | |||||||
NOPAT | 147,700 | 157,671 | 187,538 | |||||||
Net income | 76,500 -48.42% | 148,300 -6.55% | 158,700 -35.67% | |||||||
Dividends | (53,200) | (62,900) | (86,800) | |||||||
Dividend yield | 1.55% | 1.85% | 3.04% | |||||||
Proceeds from repurchase of equity | 275,200 | (199) | 24,973 | |||||||
BB yield | -8.01% | 0.01% | -0.88% | |||||||
Debt | ||||||||||
Debt current | 77,500 | 117,300 | 18,198 | |||||||
Long-term debt | 870,600 | 446,837 | 467,543 | |||||||
Deferred revenue | 69,837 | 41,295 | ||||||||
Other long-term liabilities | 39,400 | 122,434 | 41,295 | |||||||
Net debt | 30,200 | 391,440 | 257,969 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 272,300 | 161,718 | 191,709 | |||||||
CAPEX | (62,800) | (66,346) | (63,998) | |||||||
Cash from investing activities | (63,400) | (74,541) | (67,506) | |||||||
Cash from financing activities | 540,800 | (130,816) | (148,760) | |||||||
FCF | 237,323 | 59,551 | 148,471 | |||||||
Balance | ||||||||||
Cash | 912,300 | 159,029 | 206,175 | |||||||
Long term investments | 5,600 | 13,668 | 21,597 | |||||||
Excess cash | 836,935 | 90,994 | 135,231 | |||||||
Stockholders' equity | 1,910,200 | 1,629,996 | 1,589,707 | |||||||
Invested Capital | 1,969,865 | 2,040,705 | 1,937,717 | |||||||
ROIC | 7.37% | 7.93% | 9.66% | |||||||
ROCE | 6.18% | 8.89% | 10.85% | |||||||
EV | ||||||||||
Common stock shares outstanding | 129,400 | 127,100 | 128,200 | |||||||
Price | 26.55 -0.67% | 26.73 20.19% | 22.24 -48.89% | |||||||
Market cap | 3,435,570 1.12% | 3,397,383 19.16% | 2,851,168 -49.63% | |||||||
EV | 3,481,070 | 3,803,289 | 3,122,835 | |||||||
EBITDA | 251,500 | 264,002 | 295,528 | |||||||
EV/EBITDA | 13.84 | 14.41 | 10.57 | |||||||
Interest | 21,000 | 21,424 | 18,868 | |||||||
Interest/NOPBT | 11.74% | 10.88% | 8.08% |